# Parkinson's Research Results Summary

This document summarizes the results of the Parkinson's disease detection model evaluated on the current dataset.

## Evaluation Metrics

The model was evaluated using a **Late Fusion** architecture on the Parkinson's cohort (831 images).

### Classification Report
| Class | Label | Precision | Recall | F1-Score | Support |
|---|---|---|---|---|---|
| 0 | Normal | 0.74 | 1.00 | 0.85 | 610 |
| 1 | Parkinson | 1.00 | 0.01 | 0.03 | 221 |
| **Accuracy** | | | | **0.74** | **831** |

### Key Observations
- **High Overall Accuracy (74%)**: The model correctly classifies the majority of samples, but this is primarily due to the class imbalance (Normal samples are more frequent).
- **Low Recall for Parkinson (1%)**: The model is currently struggling to identify Parkinson's cases correctly. Most Parkinson's cases are being predicted as "Normal".
- **Infinite Precision**: While the precision for Parkinson's is high (1.00), it is biased by the very low number of true positive predictions.

## Visual Results

### Confusion Matrix
![Confusion Matrix](file:///d:/Machine%20Learning/Multimodal%20Neurodegenerative%20Research/results/parkinsons_confusion_matrix.png)

## Analysis & Next Steps

### The "Class Imbalance" Challenge
The current dataset has a significant imbalance between "Normal" (610) and "Parkinson" (221) samples. The model has learned a "conservative" strategy of predicting "Normal" to maintain high accuracy.

### Improvement Strategy
1.  **Hybrid Fusion**: The new Hybrid Fusion architecture (with Cross-Attention) that we just implemented is designed specifically to address this by allowing clinical features to "gate" imaging features.
2.  **Upsampling**: We can implement weighted loss or oversampling for the Parkinson's class in the next training run.
3.  **Cross-Validation**: Move from a simple split to K-Fold cross-validation to ensure results are not split-dependent.

> [!IMPORTANT]
> These results are from the **initial baseline model**. The next training run with the **Hybrid Fusion** architecture is expected to significantly improve the Recall for Parkinson's diagnosis.
